4 completed, 1 terminated. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
Follow Arrevus Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients Ceftazidime or meropenem, ARV-1801, Placebo - Melioidosis | Phase 2 | Completed | Arrevus Inc. | 125 | 2022-06-14 | 2024-02-16 |
| Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections sodium fusidate - Refractory Bone or Joint Infections | Phase 2 / Phase 3 | Completed | Arrevus Inc. | 30 | 2015-12-01 | 2020-01-30 |
| Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections sodium fusidate, linezolid - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Arrevus Inc. | 716 | 2015-11-01 | 2019-04-19 |
| Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection CEM-102, IV or Oral standard of care antibiotics, Rifampin - Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee | Phase 2 | Terminated | Arrevus Inc. | 14 | 2012-12-01 | 2019-04-19 |
| Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections CEM-102, Linezolid - Skin Diseases, Bacterial | Phase 2 | Completed | Arrevus Inc. | 198 | 2009-08-01 | 2019-04-19 |
Cellulitis (1) · Melioidosis (1) · Osteomyelitis (1) · Skin Diseases, Bacterial (1) · Staphylococcal Skin Infections (1)
Fusidic Acid (4) · Linezolid (3) · Cefazolin (1) · Ceftaroline (1) · Ceftazidime (1) · Ceftriaxone (1) · Ciprofloxacin (1) · Daptomycin (1) · Levofloxacin (1) · Meropenem (1) · Nafcillin (1) · Oxacillin (1) · Rifampin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · Vancomycin (1)
United States (4) · Puerto Rico (1) · Thailand (1)
Richard Pushkin, MD (1) · Robert Dobbins, MD, PhD (1)